Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Radioimmunoimaging of AL Amyloidosis

This study has been completed.
Food and Drug Administration (FDA)
Information provided by (Responsible Party):
Alan Solomon, University of Tennessee Identifier:
First received: July 28, 2011
Last updated: October 10, 2012
Last verified: August 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)